Skip to main content
Top
Published in: Clinical and Experimental Nephrology 2/2009

01-04-2009 | Case Report

Acute renal failure as the presenting feature of leukaemic infiltration in chronic lymphocytic leukaemia

Authors: Saman Hewamana, Chris Pepper, Chris Jenkins, Clare Rowntree

Published in: Clinical and Experimental Nephrology | Issue 2/2009

Login to get access

Abstract

Chronic lymphocytic leukaemia (CLL) is a neoplastic condition of B cells which commonly affects the lymph nodes, liver, spleen and bone marrow. Leukaemic involvement of the kidney is also relatively common in CLL, but characteristically is not associated with renal impairment. Our report describes a patient who developed acute renal failure as the initial presenting feature of CLL. The renal failure was subsequently found to be due to direct leukaemic infiltration. Treatment with chlorambucil and prednisolone resulted in stabilisation of the renal function for approximately 1 year prior to the need for long-term haemodialysis. Leukaemic infiltration of kidney should always be considered when a patient with CLL presents with renal impairment, regardless of the clinical stage, as the renal failure often responds well to chemotherapy.
Literature
1.
go back to reference Barcos M, Lane W, Gomez GA, et al. An autopsy study of 1206 acute and chronic leukaemia (1958 to 1982). Cancer 1987;60:827–37.CrossRefPubMed Barcos M, Lane W, Gomez GA, et al. An autopsy study of 1206 acute and chronic leukaemia (1958 to 1982). Cancer 1987;60:827–37.CrossRefPubMed
2.
go back to reference Xiao JC, Walz-Mattmuller R, Ruck P, Horny HP, Kaiserling E. Renal involvement in myeloproliferative and lymphoproliferative disorders. A study of autopsy cases. Gen Diagn Pathol. 1997;142:147–53.PubMed Xiao JC, Walz-Mattmuller R, Ruck P, Horny HP, Kaiserling E. Renal involvement in myeloproliferative and lymphoproliferative disorders. A study of autopsy cases. Gen Diagn Pathol. 1997;142:147–53.PubMed
3.
go back to reference Erten N, Saka B, Caliskan YK, Besisik S, Karan MA, Tascioglu C. Acute renal failure due to leukaemic infiltration in chronic lymphocytic leukaemia: case report. Int J Clin Pract Suppl. 2005;59:53–5.CrossRef Erten N, Saka B, Caliskan YK, Besisik S, Karan MA, Tascioglu C. Acute renal failure due to leukaemic infiltration in chronic lymphocytic leukaemia: case report. Int J Clin Pract Suppl. 2005;59:53–5.CrossRef
4.
go back to reference Rockx MA, Rizkalla K, Clark WF. Acute renal failure and chronic lymphocytic leukaemia. Nephrol Dial Transplant. 2008;23:770–1.CrossRefPubMed Rockx MA, Rizkalla K, Clark WF. Acute renal failure and chronic lymphocytic leukaemia. Nephrol Dial Transplant. 2008;23:770–1.CrossRefPubMed
5.
go back to reference Takei K, Horikoshi A, Hosokawa Y, Sawada S, Horie T. Successful treatment with fludarabine of chronic lymphocytic leukaemia associated with nephrotic syndrome. Rinsho Ketsueki. 2002;43:993–7.PubMed Takei K, Horikoshi A, Hosokawa Y, Sawada S, Horie T. Successful treatment with fludarabine of chronic lymphocytic leukaemia associated with nephrotic syndrome. Rinsho Ketsueki. 2002;43:993–7.PubMed
6.
go back to reference Binet JL, Auquier A, Dighiero G, et al. A new prognostic classification of chronic lymphocytic leukaemia derived from a multivariate survival analysis. Cancer. 1981;48:198–206.CrossRefPubMed Binet JL, Auquier A, Dighiero G, et al. A new prognostic classification of chronic lymphocytic leukaemia derived from a multivariate survival analysis. Cancer. 1981;48:198–206.CrossRefPubMed
8.
go back to reference Schwartz JB, Shamsuddin AM. The effects of leukaemic infiltrates in various organs in chronic lymphocytic leukaemia. Hum Pathol. 1981;12:432–40.CrossRefPubMed Schwartz JB, Shamsuddin AM. The effects of leukaemic infiltrates in various organs in chronic lymphocytic leukaemia. Hum Pathol. 1981;12:432–40.CrossRefPubMed
9.
go back to reference Pagniez DC, Fenaux P, Delvallez L, Dequiedt P, Gosselin B, Tacquet A. Reversible renal failure due to specific infiltration in chronic lymphocytic leukaemia. Am J Med. 1988;85:579–80.CrossRefPubMed Pagniez DC, Fenaux P, Delvallez L, Dequiedt P, Gosselin B, Tacquet A. Reversible renal failure due to specific infiltration in chronic lymphocytic leukaemia. Am J Med. 1988;85:579–80.CrossRefPubMed
10.
go back to reference Saggi S, Calandri C, Muhlfelder T, Choi H, Kahn T, Kaji D. Renal failure due to leukaemic infiltration in chronic lymphocytic leukaemia. Nephrol Dial Transplant. 1990;5:1051–2.CrossRefPubMed Saggi S, Calandri C, Muhlfelder T, Choi H, Kahn T, Kaji D. Renal failure due to leukaemic infiltration in chronic lymphocytic leukaemia. Nephrol Dial Transplant. 1990;5:1051–2.CrossRefPubMed
11.
go back to reference Phillips JK, Bass PS, Majumdar G, Davies DR, Jones NF, Pearson TC. Renal failure caused by leukaemic infiltration in chronic lymphocytic leukaemia. J Clin Pathol. 1993;46:1131–3.CrossRefPubMedPubMedCentral Phillips JK, Bass PS, Majumdar G, Davies DR, Jones NF, Pearson TC. Renal failure caused by leukaemic infiltration in chronic lymphocytic leukaemia. J Clin Pathol. 1993;46:1131–3.CrossRefPubMedPubMedCentral
Metadata
Title
Acute renal failure as the presenting feature of leukaemic infiltration in chronic lymphocytic leukaemia
Authors
Saman Hewamana
Chris Pepper
Chris Jenkins
Clare Rowntree
Publication date
01-04-2009
Publisher
Springer Japan
Published in
Clinical and Experimental Nephrology / Issue 2/2009
Print ISSN: 1342-1751
Electronic ISSN: 1437-7799
DOI
https://doi.org/10.1007/s10157-009-0129-y

Other articles of this Issue 2/2009

Clinical and Experimental Nephrology 2/2009 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine